Necrotic, rather than apoptotic, cell death caused by cytochrome P450–activated ifosfamide

被引:0
|
作者
Peter Karle
Matthias Renner
Brian Salmons
Walter H Günzburg
机构
[1] Institute of Virology,
[2] University of Veterinary Sciences,undefined
[3] Vienna,undefined
[4] Bavarian Nordic GmbH,undefined
[5] Austrian Nordic AG,undefined
来源
Cancer Gene Therapy | 2001年 / 8卷
关键词
Cytochrome P450 2B1; ifosfamide; necrosis; apoptosis; bystander effect; suicide gene;
D O I
暂无
中图分类号
学科分类号
摘要
Feline kidney cells were transfected with a vector overexpressing cytochrome P450 2B1 (CYP2B1). Transfected cells acquired a new specific biochemical activity, which could be demonstrated by a rapid CYP2B1 detection assay and showed selective sensitivity to the antitumorigenic prodrug ifosfamide (IFO). Further, the cell-killing effect was also mediated on nonmodified cells like feline kidney cells, mouse lymphoma, and human pancreatic cells in the vicinity of the CYP2B1-expressing cells due to the diffusible nature of the activated IFO metabolites. One of these, phosphoramide mustard, causes interstrand DNA cross-linking and it has been thought that the inability to repair this damage results in apoptosis. Surprisingly, our results clearly demonstrate a necrotic mechanism of IFO-induced cell death. This may have important implications for the activation of the immune system during CYP2B1/IFO suicide gene therapy of cancer. Cancer Gene Therapy (2001) 8, 220–230
引用
收藏
页码:220 / 230
页数:10
相关论文
共 50 条
  • [21] Exposure to benzo[A]pyrene in the hepatic cytochrome p450 oxidoreductase null mouse: Detoxification by hepatic cytochrome p450 is more important than metabolic activation
    Arit, V. M.
    Stiborova, M.
    Henderson, C. J.
    Thieniann, M.
    Frei, E.
    Singh, R.
    da Costa, G. G.
    Schmitz, O. J.
    Farmer, P. B.
    Wolf, C. R.
    Phillips, D. H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 73 - 73
  • [22] Givosiran Likely Inhibits Cytochrome P450 More Substantially Than Reported
    Bins, Sander
    Sardh, Eliane
    Langendonk, Janneke G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (01) : 24 - 24
  • [23] Drug interactions in palliative care - it's more than cytochrome P450
    Gaertner, Jan
    Ruberg, Klaus
    Schlesiger, Grit
    Frechen, Sebastian
    Voltz, Raymond
    PALLIATIVE MEDICINE, 2012, 26 (06) : 813 - 825
  • [24] Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor α
    Ng, Valerie Y.
    Huang, Yong
    Reddy, L. Manmohan
    Falck, John R.
    Lin, Emil T.
    Kroetz, Deanna L.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (07) : 1126 - 1134
  • [25] Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene
    Chen, L
    Waxman, DJ
    Chen, DS
    Kufe, DW
    CANCER RESEARCH, 1996, 56 (06) : 1331 - 1340
  • [26] The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro
    Mast, Natalia
    Fotinich, Anna
    Pikuleva, Irina A.
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (07) : 923 - 930
  • [27] Exposure to benzo(a) pyrene in the hepatic cytochrome P450 oxidoreductase (POR) null mouse:: detoxification by hepatic cytochrome P450 is more important than metabolic activation
    Arlt, Volker M.
    Stiborova, Marie
    Henderson, Colin J.
    Thiemann, Markus
    Frei, Eva
    Aimova, Dagmar
    Singh, Rajinder
    da Costa, Goncalo Gamboa
    Schmitz, Oliver J.
    Farmer, Peter B.
    Wolf, C. Roland
    Phillips, David H.
    MUTAGENESIS, 2007, 22 (06) : 439 - 439
  • [28] Apoptotic and necrotic death mechanisms are concomitantly activated in the same cell after cerebral ischemia
    Ünal-Çevik, I
    Kilinç, M
    Can, A
    Gürsoy-Özdemir, Y
    Dalkara, T
    STROKE, 2004, 35 (09) : 2189 - 2194
  • [29] Characterization of THLE-Cytochrome P450 (P450) Cell Lines: Gene Expression Background and Relationship to P450-Enzyme Activity
    Soltanpour, Yalda
    Hilgendorf, Constanze
    Ahlstrom, Marie M.
    Foster, Alison J.
    Kenna, J. Gerry
    Petersen, Anne
    Ungell, Anna-Lena
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (11) : 2054 - 2058
  • [30] Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells
    Jeon, Yu Jin
    Kim, Joong Sun
    Hwang, Geun Hye
    Wu, Zhexue
    Han, Ho Jae
    Park, Soo Hyun
    Chang, Woochul
    Kim, Lark Kyun
    Lee, You-Mie
    Liu, Kwang-Hyeon
    Lee, Min Young
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 764 : 480 - 488